Cargando…
Characteristics of pncA mutations in multidrug-resistant tuberculosis in Taiwan
BACKGROUND: Pyrazinamide (PZA) is an important first-line drug in multidrug-resistant tuberculosis (MDRTB) treatment. However, the unreliable results obtained from traditional susceptibility testing limits its usefulness in clinical settings. The detection of pncA gene mutations is a potential surro...
Autores principales: | Chiu, Yu-Chi, Huang , Shiang-Fen, Yu, Kwok-Woon, Lee, Yu-Chin, Feng, Jia-Yih, Su, Wei-Juin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180675/ https://www.ncbi.nlm.nih.gov/pubmed/21910892 http://dx.doi.org/10.1186/1471-2334-11-240 |
Ejemplares similares
-
Pyrazinamide Resistance and pncA Mutation Profiles in Multidrug Resistant Mycobacterium Tuberculosis
por: Shi, Dawei, et al.
Publicado: (2022) -
pncA Mutations in the Specimens from Extrapulmonary Tuberculosis
por: Lee, Jaechun, et al.
Publicado: (2012) -
Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Korea.
por: Lee, K. W., et al.
Publicado: (2001) -
pncA mutations in clinical Mycobacterium tuberculosis isolates from Korea
por: Park, Soon Kew, et al.
Publicado: (2001) -
Pyrazinamide Susceptibility and pncA Mutation Profiles of Mycobacterium tuberculosis among Multidrug-Resistant Tuberculosis Patients in Bangladesh
por: Rahman, Arfatur, et al.
Publicado: (2017)